Van Dam D - Search Results

1

Altered circadian locomotor activity in APP23 mice: a model for BPSD disturbances.

Vloeberghs E, Van Dam D, Engelborghs S, Nagels G, Staufenbiel M, De Deyn PP. Vloeberghs E, et al. Among authors: van dam d. Eur J Neurosci. 2004 Nov;20(10):2757-66. doi: 10.1111/j.1460-9568.2004.03755.x. Eur J Neurosci. 2004. PMID: 15548219

2

Spatial learning, contextual fear conditioning and conditioned emotional response in Fmr1 knockout mice.

Van Dam D, D'Hooge R, Hauben E, Reyniers E, Gantois I, Bakker CE, Oostra BA, Kooy RF, De Deyn PP. Van Dam D, et al. Among authors: d hooge r. Behav Brain Res. 2000 Dec 20;117(1-2):127-36. doi: 10.1016/s0166-4328(00)00296-5. Behav Brain Res. 2000. PMID: 11099766

3

Hyperactivity, neuromotor defects, and impaired learning and memory in a mouse model for metachromatic leukodystrophy.

D'Hooge R, Van Dam D, Franck F, Gieselmann V, De Deyn PP. D'Hooge R, et al. Among authors: van dam d. Brain Res. 2001 Jul 13;907(1-2):35-43. doi: 10.1016/s0006-8993(01)02374-5. Brain Res. 2001. PMID: 11430883

4

Age-dependent cognitive decline in the APP23 model precedes amyloid deposition.

Van Dam D, D'Hooge R, Staufenbiel M, Van Ginneken C, Van Meir F, De Deyn PP. Van Dam D, et al. Among authors: d hooge r, van ginneken c, van meir f. Eur J Neurosci. 2003 Jan;17(2):388-96. doi: 10.1046/j.1460-9568.2003.02444.x. Eur J Neurosci. 2003. PMID: 12542676

5

Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model.

Van Dam D, Abramowski D, Staufenbiel M, De Deyn PP. Van Dam D, et al. Psychopharmacology (Berl). 2005 Jun;180(1):177-90. doi: 10.1007/s00213-004-2132-z. Epub 2005 Jan 15. Psychopharmacology (Berl). 2005. PMID: 15654502

6

GSA: behavioral, histological, electrophysiological and neurochemical effects.

Torremans A, Marescau B, Van Dam D, Van Ginneken C, Van Meir F, Van Bogaert PP, D'Hooge R, de Vente J, De Deyn PP. Torremans A, et al. Among authors: van bogaert pp, van dam d, d hooge r, van ginneken c, van meir f. Physiol Behav. 2005 Feb 15;84(2):251-64. doi: 10.1016/j.physbeh.2004.12.001. Epub 2005 Jan 8. Physiol Behav. 2005. PMID: 15708777

7

Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models.

Van Dam D, Marescau B, Engelborghs S, Cremers T, Mulder J, Staufenbiel M, De Deyn PP. Van Dam D, et al. Neurochem Int. 2005 Apr;46(5):409-22. doi: 10.1016/j.neuint.2004.11.005. Epub 2005 Jan 17. Neurochem Int. 2005. PMID: 15737439

8

APP23 mice as a model of Alzheimer's disease: an example of a transgenic approach to modeling a CNS disorder.

Van Dam D, Vloeberghs E, Abramowski D, Staufenbiel M, De Deyn PP. Van Dam D, et al. CNS Spectr. 2005 Mar;10(3):207-22. doi: 10.1017/s1092852900010051. CNS Spectr. 2005. PMID: 15744222 Review.

9

Biochemical and behavioural phenotyping of a mouse model for GAMT deficiency.

Torremans A, Marescau B, Possemiers I, Van Dam D, D'Hooge R, Isbrandt D, De Deyn PP. Torremans A, et al. Among authors: van dam d, d hooge r. J Neurol Sci. 2005 Apr 15;231(1-2):49-55. doi: 10.1016/j.jns.2004.12.014. J Neurol Sci. 2005. PMID: 15792821

10

Cognitive decline, neuromotor and behavioural disturbances in a mouse model for fragile-X-associated tremor/ataxia syndrome (FXTAS).

Van Dam D, Errijgers V, Kooy RF, Willemsen R, Mientjes E, Oostra BA, De Deyn PP. Van Dam D, et al. Behav Brain Res. 2005 Jul 30;162(2):233-9. doi: 10.1016/j.bbr.2005.03.007. Behav Brain Res. 2005. PMID: 15876460

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

251 results

Search Page

Filters